Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.030
-0.030 (-2.83%)
At close: Dec 5, 2025, 4:00 PM EST
1.000
-0.030 (-2.91%)
After-hours: Dec 5, 2025, 7:16 PM EST
Lucid Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 4.4 | 4.35 | 2.43 | 0.38 | 0.5 | - | |
| Revenue Growth (YoY) | 5.01% | 79.00% | 544.03% | -24.60% | - | - | |
| Cost of Revenue | 6.96 | 7.1 | 5.98 | 3.61 | 0.59 | - | |
| Gross Profit | -2.56 | -2.75 | -3.55 | -3.24 | -0.09 | - | |
| Selling, General & Admin | 39.62 | 36.62 | 35.66 | 40.11 | 18.04 | 2.84 | |
| Research & Development | 5.41 | 5.99 | 7.25 | 11.26 | 9.3 | 5.44 | |
| Amortization of Goodwill & Intangibles | 0.42 | 0.69 | 2.02 | 1.65 | - | - | |
| Operating Expenses | 45.45 | 43.3 | 44.93 | 53.01 | 27.33 | 8.28 | |
| Operating Income | -48 | -46.05 | -48.48 | -56.25 | -27.42 | -8.28 | |
| Interest Expense | -0.02 | -0.03 | -0.42 | -0.01 | -0.66 | - | |
| Interest & Investment Income | 0.34 | 0.32 | 0.42 | 0.09 | - | - | |
| Other Non Operating Income (Expenses) | - | - | -1.19 | - | - | - | |
| EBT Excluding Unusual Items | -47.69 | -45.76 | -49.66 | -56.17 | -28.08 | -8.28 | |
| Other Unusual Items | -5.6 | 0.23 | -3.01 | - | - | - | |
| Pretax Income | -53.29 | -45.53 | -52.67 | -56.17 | -28.08 | -8.28 | |
| Net Income | -53.29 | -45.53 | -52.67 | -56.17 | -28.08 | -8.28 | |
| Preferred Dividends & Other Adjustments | 12.56 | 7.5 | - | - | - | - | |
| Net Income to Common | -65.84 | -53.03 | -52.67 | -56.17 | -28.08 | -8.28 | |
| Shares Outstanding (Basic) | 84 | 51 | 42 | 36 | 19 | 14 | |
| Shares Outstanding (Diluted) | 84 | 51 | 42 | 36 | 19 | 14 | |
| Shares Change (YoY) | 80.04% | 20.98% | 15.44% | 94.44% | 31.81% | 0.03% | |
| EPS (Basic) | -0.79 | -1.05 | -1.26 | -1.55 | -1.51 | -0.59 | |
| EPS (Diluted) | -0.79 | -1.05 | -1.26 | -1.55 | -1.51 | -0.59 | |
| Free Cash Flow | -44.18 | -44.44 | -33.04 | -30.59 | -18.53 | -5.63 | |
| Free Cash Flow Per Share | -0.53 | -0.88 | -0.79 | -0.85 | -1.00 | -0.40 | |
| Gross Margin | -58.10% | -63.35% | -146.25% | - | -17.00% | - | |
| Operating Margin | -1091.25% | -1059.64% | -1996.79% | -14920.69% | -5483.80% | - | |
| Profit Margin | -1496.80% | -1220.09% | -2169.11% | -14899.47% | -5615.60% | - | |
| Free Cash Flow Margin | -1004.39% | -1022.46% | -1360.71% | -8114.85% | -3706.00% | - | |
| EBITDA | -47.12 | -44.89 | -45.98 | -54.32 | -27.42 | - | |
| D&A For EBITDA | 0.89 | 1.17 | 2.5 | 1.94 | 0 | - | |
| EBIT | -48 | -46.05 | -48.48 | -56.25 | -27.42 | -8.28 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.